Relationships between blood-brain barrier breakdown, Alzheimer's disease pathology, and memory in aging
血脑屏障破坏、阿尔茨海默病病理学和衰老记忆之间的关系
基本信息
- 批准号:10387988
- 负责人:
- 金额:$ 4.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAgeAgingAlbuminsAlzheimer disease detectionAlzheimer&aposs DiseaseAlzheimer&aposs disease pathologyAlzheimer’s disease biomarkerAmyloidAmyloid beta-ProteinAppearanceAreaAtrophicBloodBlood - brain barrier anatomyBlood TestsBlood VesselsBrainBrain regionClinicalCognitionCognitiveCommunicationCross-Sectional StudiesData AnalysesDepositionDetectionDevelopmentDiagnosisDiseaseEarly DiagnosisEarly InterventionEducational process of instructingElderlyEpisodic memoryEtiologyEventExtravasationFellowshipFunctional disorderGoalsHippocampus (Brain)HomeHomeostasisHumanImpaired cognitionImpairmentInferiorInstitutesLeadLongitudinal StudiesMagnetic Resonance ImagingMeasuresMedialMediatingMemoryMentorsMethodsMultimodal ImagingNerve DegenerationNeuronal InjuryNeuropsychological TestsNeurosciencesOutcomePathogenesisPathologicPathologic ProcessesPathologyPathway interactionsPatientsPerformancePositron-Emission TomographyPostdoctoral FellowProteinsResearchResearch PersonnelResearch Project GrantsResearch TrainingRoleSamplingSecureStudentsSymptomsTemporal LobeTestingTracerTrainingVascular Diseasesabeta accumulationabeta depositionage relatedbaseblood-brain barrier disruptionblood-brain barrier permeabilizationcareercareer developmentcerebral atrophycontrast enhanceddesignearly detection biomarkershealthy agingimaging biomarkerimaging facilitiesimaging modalityin vivoinnovationinsightmultimodal neuroimagingneuroimagingneurotoxicneurovascularnormal agingnovelpharmacokinetic modelprotein aggregationskillsstatisticstau Proteinstau aggregationtheoriestherapy developmenttreatment strategyvascular injuryyoung adult
项目摘要
Project Summary
The major theory of causation for Alzheimer’s disease (AD) is deposition of the protein β-amyloid, however it is
unclear how aging influences amyloid accumulation or why cognitive decline can occur in its absence. Evidence
suggests that neurovascular dysfunction, such as the breakdown of the blood-brain barrier (BBB), is related to
neurodegeneration and cognitive impairment, and that this relationship may occur independently of amyloid.
However, the direct relationship between BBB breakdown and AD biomarkers, as well as cognition, has not been
thoroughly investigated in humans. The aim of this study is to use a novel multi-modal imaging design to examine
how BBB breakdown in humans is related to AD biomarkers of atrophy, amyloid and tau, and cognition. BBB
breakdown will be quantified in vivo using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI),
which allows for the detection of subtle BBB leakage in the human brain. Both tau and Aβ will be measured in
vivo using the positron emission tomography (PET) tracers [18F] Flortaucipir and [11C] PiB, respectively.
Neurodegeneration will be measured with structural MRI and episodic memory with a composite
neuropsychological test score. Aim 1 will determine if BBB breakdown increases with age and if there are specific
regions that are more vulnerable during normal aging. Aim 2 will examine if BBB breakdown in the temporal lobe
is related to greater global Aβ and regional tau. In addition, it will be determined if BBB breakdown is associated
with greater retrospective longitudinal Aβ and tau accumulation. Finally, Aim 3 will determine if BBB breakdown
in the temporal lobe is related to smaller temporal lobe volumes and worse memory performance. Relationships
between BBB breakdown and retrospective longitudinal change in memory performance, independent of amyloid
and tau, will also be examined. The findings from this study will help unravel fundamental mechanisms of AD
pathogenesis in the human brain, which has vital implications for early detection and the development of new
treatment strategies for AD. The proposed research project will achieve the applicant’s training goals, which
include (1) developing skills in multimodal imaging, (2) advanced statistics and data analysis training, (3) training
in clinical impairment and pathophysiology of AD, (4) development of teaching and mentoring skills, (5)
improvement of effective scientific communication skills, and (6) career development. UC Berkeley’s Helen Wills
Neuroscience Institute is home to a network of cutting-edge researchers and world-class imaging facilities. The
sponsor of the project, Dr. William Jagust, is at the forefront in applying multimodal neuroimaging methods to
study questions of aging and AD. He also has successfully mentored numerous students in the past, who have
become leaders in the field. The co-sponsor, Dr. Suzanne Baker, is an expert in optimization of neuroimaging
quantification for both PET and MRI, as well as pharmacokinetic modeling. Both the proposed research and the
training plan will provide the applicant with the skillset to secure a competitive post-doctoral fellowship and a
successful research career studying aging and AD.
项目摘要
阿尔茨海默病(AD)的主要病因理论是β-淀粉样蛋白的沉积,然而,
不清楚衰老如何影响淀粉样蛋白的积累,也不清楚为什么在淀粉样蛋白缺失的情况下会发生认知能力下降。证据
表明神经血管功能障碍,如血脑屏障(BBB)的破坏,与
神经变性和认知障碍,这种关系可能独立于淀粉样蛋白发生。
然而,BBB破坏和AD生物标志物以及认知之间的直接关系还没有得到证实。
在人类中进行了彻底的研究。本研究的目的是使用一种新的多模态成像设计来检查
人类的血脑屏障破坏如何与萎缩、淀粉样蛋白和tau蛋白以及认知的AD生物标志物相关。BBB
使用动态对比增强磁共振成像(DCE-MRI)在体内定量分解,
其允许检测人脑中细微的BBB渗漏。tau和Aβ均将在
分别使用正电子发射断层扫描(PET)示踪剂[18 F] Flortaucipir和[11 C] PiB体内。
神经退行性病变将通过结构MRI和情景记忆测量,
神经心理学测试评分。目标1将确定BBB崩溃是否随年龄增长而增加,
在正常衰老过程中更脆弱的区域。目标2将检查颞叶中的BBB是否崩溃
与更大的全球Aβ和区域tau蛋白有关。此外,还将确定BBB击穿是否与
具有更大的回顾性纵向Aβ和tau累积。最后,目标3将确定BBB是否击穿
大脑颞叶的体积较小,记忆力也较差。关系
BBB崩溃和记忆表现的回顾性纵向变化之间的关系,独立于淀粉样蛋白
和tau,也将被检查。这项研究的结果将有助于揭示AD的基本机制
发病机制在人类大脑中,这对早期发现和新的发展具有重要意义。
AD的治疗策略拟议的研究项目将实现申请人的培训目标,
包括(1)发展多模式成像技能,(2)高级统计和数据分析培训,(3)培训
在AD的临床损伤和病理生理学方面,(4)发展教学和指导技能,(5)
提高有效的科学沟通技能;(6)职业发展。加州大学伯克利分校的海伦·威尔斯
神经科学研究所拥有尖端研究人员网络和世界一流的成像设施。的
该项目的发起人William Jagust博士在应用多模式神经成像方法方面处于最前沿,
研究衰老和AD的问题。他还成功地指导了许多学生在过去,谁有
成为该领域的领导者。共同发起人Suzanne Baker博士是神经成像优化方面的专家
PET和MRI的定量以及药代动力学建模。无论是拟议的研究和
培训计划将为申请人提供技能,以确保有竞争力的博士后奖学金和
成功的研究事业,研究衰老和AD。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marisa Nicole Denkinger其他文献
Marisa Nicole Denkinger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marisa Nicole Denkinger', 18)}}的其他基金
Relationships between blood-brain barrier breakdown, Alzheimer's disease pathology, and memory in aging
血脑屏障破坏、阿尔茨海默病病理学和衰老记忆之间的关系
- 批准号:
10799538 - 财政年份:2022
- 资助金额:
$ 4.27万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 4.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 4.27万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 4.27万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 4.27万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 4.27万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 4.27万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 4.27万 - 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 4.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 4.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 4.27万 - 项目类别:
Operating Grants